To describe the determinants of survival for patients with floor of mouth (FOM) squamous cell carcinoma (SCC) from 1973 to 2013 with the SEER database (Surveillance, Epidemiology, and End Results).
Study Design and Setting
Retrospective cohort study with a national database.
Subjects and Methods
The SEER registry was utilized to calculate survival trends for patients with FOM SCC between 1973 and 2013. Patient data were analyzed with respect to age, sex, race, primary site, stage at presentation, tumor size, grade, and treatment modalities (surgery and radiotherapy). Overall survival (OS) and disease-specific survival (DSS) were calculated.
Results
A total of 14,010 FOM SCC cases were identified. The cohort was 69.5% male, and the median age at diagnosis was 62 years. Forty-six percent of cases were treated with surgery, while 14% received radiotherapy. Kaplan-Meier analysis demonstrated OS and DSS of 39% and 59% at 5 years, respectively. Multivariate analysis showed that age, grade, stage, size, and surgery were determinants for OS and DSS (all P < .05). For early- and advanced-stage cancers, age, grade, size, and surgery predicted OS and DSS, while radiotherapy was a predictor of OS and DSS in advanced-stage tumors only (all P < .05).
Conclusion
To our knowledge, this study is the largest to date investigating prognostic factors for survival of patients diagnosed with FOM SCC. Determinants of survival include age, grade, stage, size, and surgery. Surgery appears to play a critical role in the management of these tumors.
GattaGBottaLSánchezMJet al. Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer. 2015;51:2130-2143.
2.
Van DijkBACGattaGCapocacciaRPierannunzioDStrojanPLicitraL.Rare cancers of the head and neck area in Europe. Eur J Cancer. 2012;48:783-796.
3.
GaravelloWBertuccioPLeviFet al. The oral cancer epidemic in central and eastern Europe. Int J Cancer. 2010;127:160-171.
4.
JemalABrayFCenterMMFerlayJWardEFormanD.Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
5.
FunkGFKarnellLHRobinsonRAZhenWKTraskDKHoffmanHT.Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report. Head Neck. 2002;24:165-180.
6.
LiRFakhryCKochWMGourinCG.The effect of tumor subsite on short-term outcomes and costs of care after oral cancer surgery. Laryngoscope. 2013;123:1652-1659.
7.
PatelSCCarpenterWRTyreeSet al. Increasing incidence of oral tongue squamous cell carcinoma in young white women, age 18 to 44 years. J Clin Oncol. 2011;29:1488-1494.
8.
KochWMMcQuoneS.Clinical and molecular aspects of squamous cell carcinoma of the head and neck in the nonsmoker and nondrinker. Curr Opin Oncol. 1997;9:257-261.
9.
LlewellynCJohnsonNWarnakulasuriyaKAA. Risk factors for squamous cell carcinoma of the oral cavity in young people—a comprehensive literature review. Oral Oncol. 2001;37:401-418.
10.
HicksWLLoreeTRGarciaRIet al. Squamous cell carcinoma of the floor of mouth: a 20-year review. Head Neck. 1997;19:400-405.
11.
FivesCNaeARochePet al. Impact of mandibular invasion on prognosis in oral squamous cell carcinoma four centimeters or less in size. Laryngoscope. 2017;127:849-854.
12.
LuryiALChenMMMehraSRomanSASosaJAJudsonBL.Positive surgical margins in early stage oral cavity cancer. Otolaryngol Neck Surg. 2014;151:984-990.
13.
RajuRGadakhSGopalPet al. Differential ligand-signaling network of CCL19/CCL21-CCR7 system. Database. 2015;2015:1-6.
14.
SiegelRMaJZouZJemalA.Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
15.
ShahaAR.Marginal mandibulectomy for carcinoma of the floor of the mouth. J Surg Oncol. 1992;49:116-119.
16.
RadoïLPaget-BaillySCyrDet al. Tobacco smoking, alcohol drinking and risk of oral cavity cancer by subsite: results of a French population-based case-control study, the ICARE study. Eur J Cancer Prev. 2013;22:268-276.
17.
ChaturvediAKEngelsEAAndersonWFGillisonMLHopkinsJ.Incidence trends for human papillomavirus–related and –unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26:612-619.
18.
FakhryCWestraWHLiSet al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. JNCI J Natl Cancer Inst. 2008;100:261-269.
19.
FivesCFeeleyLO’LearyGSheahanP.Importance of lymphovascular invasion and invasive front on survival in floor of mouth cancer. Head Neck. 2016;38(suppl 1):E1528-E1534.
20.
SessionsDGSpectorGJLenoxJet al. Analysis of treatment results for floor-of-mouth cancer. Laryngoscope. 2000;110:1764-1772.
21.
SowderJCCannonRBBuchmannLOet al. Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: a population-based study. Head Neck. 2017;39:876-880.
22.
ShiboskiCHShiboskiSCSilvermanS.Trends in oral cancer rates in the United States, 1973-1996. Community Dent Oral Epidemiol. 2000;28:249-256.
23.
ChenJJShahJLHarrisJPet al. Clinical outcomes in elderly patients treated for oral cavity squamous cell carcinoma. Int J Radiat Oncol. 2017;98:775-783.
24.
MenezesMBLehnCNGoncalvesAJ.Epidemiological and histopathological data and E-cadherin-like prognostic factors in early carcinomas of the tongue and floor of mouth. Oral Oncol. 2007;43:656-661.
25.
Osazuwa-PetersNMassaSTChristopherKMWalkerRJVarvaresMA.Race and sex disparities in long-term survival of oral and oropharyngeal cancer in the United States. J Cancer Res Clin Oncol. 2016;142:521-528.
26.
SpiroRHHuvosAGWongGYSpiroJDGneccoCAStrongEW.Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg. 1986;152:345-350.
27.
WallworkBDAndersonSRComanWB.Squamous cell carcinoma of the floor of the mouth: tumour thickness and the rate of cervical metastasis. ANZ J Surg. 2007;77:761-764.
28.
HuangSHHwangDLockwoodGGoldsteinDPO’SullivanB.Predictive value of tumor thickness for cervical lymph-node involvement in squamous cell carcinoma of the oral cavity: a meta-analysis of reported studies. Cancer. 2009;115:1489-1497.
29.
AygunCSalazarOMSewchandWAmornmarnRPrempreeT.Carcinoma of the floor of the mouth: a 20-year experience. Int J Radiat Oncol Biol Phys. 1984;10:619-626.
30.
BegganCFivesCO’LearyGSheahanPHeffronCCFeeleyL.Pattern of invasion and lymphovascular invasion in squamous cell carcinoma of the floor of the mouth: an interobserver variability study. Histopathology. 2016;69:914-920.
31.
KademaniDBellRBBagheriSet al. Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic grade. J Oral Maxillofac Surg. 2005;63:1599-1605.
32.
SmeeRIBroadleyKBridgerGPWilliamsJ.Floor of mouth carcinoma: surgery still the dominant mode of treatment. J Med Imaging Radiat Oncol. 2012;56:338-346.
33.
FuKKLichterAGalanteM.Carcinoma of the floor of mouth: an analysis of treatment results and the sites and causes of failures. Int J Radiat Oncol. 1976;1:829-837.
34.
PfisterDGSpencerSBrizelDMet al. Head and neck cancers, version 22014: clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014;12:1454-1487.
35.
GlennyA-MFurnessSWorthingtonHVet al. Interventions for the treatment of oral cavity and oropharyngeal cancer: radiotherapy. In: GlennyA-M ed. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons Ltd; 2010.
36.
JardimJFFranciscoALNGondakRDamascenaAKowalskiLP.Prognostic impact of perineural invasion and lymphovascular invasion in advanced stage oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2015;44:23-28.
37.
RogersSNBrownJSWoolgarJAet al. Survival following primary surgery for oral cancer. Oral Oncol. 2009;45:201-211.
38.
EbrahimiAGilZAmitMet al. Primary tumor staging for oral cancer and a proposed modification incorporating depth of invasion. JAMA Otolaryngol Neck Surg. 2014;140:1138.
39.
KlotchDWMuro-CachoCGalTJ.Factors affecting survival for floor-of-mouth carcinoma. Otolaryngol Head Neck Surg. 2000;122:495-498.
40.
LoreeTRStrongEW.Significance of positive margins in oral cavity squamous carcinoma. Am J Surg. 1990;160:410-414.
41.
BadranKJaniP.How to avoid accidental burns during anterior nasal cautery. Clin Otolaryngol. 2006;31:236-237.
42.
KaoJLavafATengMSHuangDGendenEM.Adjuvant radiotherapy and survival for patients with node-positive head and neck cancer: an analysis by primary site and nodal stage. Int J Radiat Oncol. 2008;71:362-370.
43.
ShrimeMGGullanePJDawsonLet al. The impact of adjuvant radiotherapy on survival in T1-2N1 squamous cell carcinoma of the oral cavity. Arch Otolaryngol Neck Surg. 2010;136:225.
44.
RodgersLWStringerSPMendenhallWMParsonsJTCassisiNJMillionRR.Management of squamous cell carcinoma of the floor of mouth. Head Neck. 1993;15:16-19.
